Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer
Conditions
- Chronic Myeloproliferative Disorders
- Graft Versus Host Disease
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Diseases
Interventions
- BIOLOGICAL: filgrastim
- DRUG: cyclophosphamide
- DRUG: fludarabine phosphate
- DRUG: mycophenolate mofetil
- DRUG: tacrolimus
- PROCEDURE: allogeneic bone marrow transplantation
- PROCEDURE: peripheral blood stem cell transplantation
- RADIATION: radiation therapy
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators